摘要
目的:总结92例原发性肝癌介入治疗的疗效。方法:对92例原发性肝癌患者的临床资料、介入治疗手段和随访资料进行回顾性分析。结果:84例患者得到随访,随访率91·3%;全组患者1、2、3年生存率分别为32·1%、20·4%和11·6%;其中经肝动脉化疗栓塞(TACE)的近期有效率(完全缓解+部分缓解)分别为37·3%和51·0%,1、2、3年生存率分别为59·3%和40·7%和16·7%;经肝动脉化疗灌注(TAI)治疗的近期有效率(完全缓解+部分缓解)分别为9·4%和12·5%,1、2年的生存率为9%和0%;治疗中,癌灶对门静脉和肝静脉有无侵犯对TACE或TAI的疗效有重要意义,介入治疗后辅以中药治疗能提高患者的生存质量。结论:应用合理的个体化治疗能提高原发性肝癌介入治疗的疗效。
Purpose： To verify effect of interventional therapy for the advanced hepatocellular carcinoma （HCC）, Materials and Methods： The clinical data of 92 cases achnitted to our hospital was analyzed retrospectively, Results： 84 patients were followed up from 2 to 38 months; the overall 1, 2, 3 year survival rates were 32,1%, 20,4%, 11.6% ; The response rate （CR ＋ PR） of the transcatheter arterial chemoembolization （TACE） was 37.3%, 51.0%, The 1, 2, 3 year survival rates were 59.3%, 40.7%, 16.7%. The response rate （CR＋PR） of the transcateter arterial infusion （TAI） was 9.4%, 12.5%, The 1, 2 year survival rates were 9% and 0% after TAI, liver or portal vein was itifiltration after treatment of the interventional therapy was effective to reduce the survival rates, Treatment of chinese medicine after interventional therapy was effective to enhance the survival quality， Conclusion： the rational and scientific interventional therapy is important to prolong survival time of the patients with HCC。
出处
《现代医用影像学》
2005年第3期106-108,共3页
Modern Medical Imageology
